(unaudited)
|
2023
|
vs 2022
|
2023
|
vs 2022
| |
First Half
| |||||
Underlying sales growth (USG)
|
9.1%
|
Turnover
|
€30.4bn
|
2.7%
| |
Beauty & Wellbeing
|
9.1%
|
Beauty & Wellbeing
|
€6.2bn
|
8.6%
| |
Personal Care
|
10.8%
|
Personal Care
|
€6.9bn
|
7.3%
| |
Home Care
|
8.4%
|
Home Care
|
€6.2bn
|
3.0%
| |
Nutrition
|
10.4%
|
Nutrition
|
€6.6bn
|
(7.1)%
| |
Ice Cream
|
5.7%
|
Ice Cream
|
€4.5bn
|
3.9%
| |
Underlying operating profit
|
€5.2bn
|
3.3%
|
Operating profit
|
€5.5bn
|
22.6%
|
Underlying operating margin
|
17.1%
|
10bps
|
Operating margin
|
18.1%
|
290bps
|
Underlying earnings per share
|
€1.39
|
3.9%
|
Diluted earnings per share
|
€1.40
|
23.6%
|
Free cash flow
|
€2.5bn
|
€0.2bn
|
Net profit
|
€3.9bn
|
20.7%
|
Second Quarter
| |||||
USG
|
7.9%
|
Turnover
|
€15.7bn
|
(0.4)%
| |
Quarterly dividend payable in September 2023
|
€0.4268 per share (a)
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover change
|
UOM%
|
Change in UOM
|
First Half
|
€30.4bn
|
9.1%
|
(0.2)%
|
9.4%
|
(2.7)%
|
(3.2)%
|
2.7%
|
17.1%
|
10bps
|
Second Quarter
|
€15.7bn
|
7.9%
|
(0.3)%
|
8.2%
|
(2.6)%
|
(5.2)%
|
(0.4)%
|
First Half 2023
|
Second Quarter 2023
| ||||||||
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Change in UOM
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€30.4bn
|
9.1%
|
(0.2)%
|
9.4%
|
10bps
|
€15.7bn
|
7.9%
|
(0.3)%
|
8.2%
|
Beauty & Wellbeing
|
€6.2bn
|
9.1%
|
3.8%
|
5.1%
|
0bps
|
€3.1bn
|
8.8%
|
4.9%
|
3.7%
|
Personal Care
|
€6.9bn
|
10.8%
|
3.2%
|
7.3%
|
(10)bps
|
€3.5bn
|
9.0%
|
3.4%
|
5.4%
|
Home Care
|
€6.2bn
|
8.4%
|
(2.5)%
|
11.2%
|
30bps
|
€3.0bn
|
6.7%
|
(2.1)%
|
9.0%
|
Nutrition
|
€6.6bn
|
10.4%
|
(1.9)%
|
12.6%
|
80bps
|
€3.3bn
|
8.9%
|
(2.6)%
|
11.8%
|
Ice Cream
|
€4.5bn
|
5.7%
|
(5.2)%
|
11.5%
|
(100)bps
|
€2.8bn
|
5.6%
|
(5.8)%
|
12.1%
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover change
|
UOM%
|
Change in UOM
|
First Half
|
€6.2bn
|
9.1%
|
3.8%
|
5.1%
|
2.6%
|
(3.0)%
|
8.6%
|
18.9%
|
0bps
|
Second Quarter
|
€3.1bn
|
8.8%
|
4.9%
|
3.7%
|
1.9%
|
(5.5)%
|
4.8%
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover change
|
UOM%
|
Change in UOM
|
First Half
|
€6.9bn
|
10.8%
|
3.2%
|
7.3%
|
(0.3)%
|
(2.9)%
|
7.3%
|
20.0%
|
(10)bps
|
Second Quarter
|
€3.5bn
|
9.0%
|
3.4%
|
5.4%
|
(0.6)%
|
(5.0)%
|
2.9%
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover change
|
UOM%
|
Change in UOM
|
First Half
|
€6.2bn
|
8.4%
|
(2.5)%
|
11.2%
|
-%
|
(5.0)%
|
3.0%
|
12.3%
|
30bps
|
Second Quarter
|
€3.0bn
|
6.7%
|
(2.1)%
|
9.0%
|
-%
|
(7.3)%
|
(1.1)%
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover change
|
UOM%
|
Change in UOM
|
First Half
|
€6.6bn
|
10.4%
|
(1.9)%
|
12.6%
|
(13.1)%
|
(3.2)%
|
(7.1)%
|
18.4%
|
80bps
|
Second Quarter
|
€3.3bn
|
8.9%
|
(2.6)%
|
11.8%
|
(12.6)%
|
(4.7)%
|
(9.3)%
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
A&D
|
Currency
|
Turnover change
|
UOM%
|
Change in UOM
|
First Half
|
€4.5bn
|
5.7%
|
(5.2)%
|
11.5%
|
-%
|
(1.7)%
|
3.9%
|
15.0%
|
(100)bps
|
Second Quarter
|
€2.8bn
|
5.6%
|
(5.8)%
|
12.1%
|
-%
|
(3.3)%
|
2.1%
|
First Half 2023
|
Second Quarter 2023
| |||||||
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€30.4bn
|
9.1%
|
(0.2)%
|
9.4%
|
€15.7bn
|
7.9%
|
(0.3)%
|
8.2%
|
Asia Pacific Africa
|
€13.4bn
|
9.1%
|
1.1%
|
8.0%
|
€6.7bn
|
8.3%
|
1.8%
|
6.5%
|
The Americas
|
€10.9bn
|
10.6%
|
1.8%
|
8.6%
|
€5.7bn
|
9.5%
|
2.9%
|
6.4%
|
Europe
|
€6.1bn
|
6.4%
|
(6.8)%
|
14.2%
|
€3.3bn
|
4.3%
|
(9.7)%
|
15.5%
|
First Half 2023
|
Second Quarter 2023
| |||||||
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Turnover
|
USG
|
UVG
|
UPG
|
Emerging markets
|
€17.7bn
|
10.6%
|
0.6%
|
10.0%
|
€9.0bn
|
9.7%
|
1.3%
|
8.3%
|
Developed markets
|
€12.7bn
|
6.9%
|
(1.4)%
|
8.4%
|
€6.7bn
|
5.4%
|
(2.4)%
|
8.0%
|
North America
|
€6.7bn
|
7.4%
|
2.0%
|
5.3%
|
€3.5bn
|
6.7%
|
3.0%
|
3.6%
|
Latin America
|
€4.2bn
|
16.3%
|
1.6%
|
14.5%
|
€2.2bn
|
14.3%
|
2.8%
|
11.1%
|
First half average rate in 2023
|
First half average rate in 2022
| |
Brazilian Real (€1 = BRL)
|
5.493
|
5.538
|
Chinese Yuan (€1 = CNY)
|
7.475
|
7.083
|
Indian Rupee (€1 = INR)
|
88.860
|
83.337
|
Indonesia Rupiah (€1 = IDR)
|
16,277
|
15,798
|
Philippine Peso (€1 = PHP)
|
59.674
|
56.969
|
UK Pound Sterling (€1 = GBP)
|
0.877
|
0.842
|
US Dollar (€1 = US $)
|
1.081
|
1.094
|
€ million
|
First Half
| |
(unaudited)
|
2023
|
2022
|
Operating profit
|
5,516
|
4,500
|
Non-underlying items within operating profit (see note 2)
|
(308)
|
544
|
Underlying operating profit
|
5,208
|
5,044
|
Turnover
|
30,428
|
29,623
|
Operating margin (%)
|
18.1
|
15.2
|
Underlying operating margin (%)
|
17.1
|
17.0
|
€ million
|
First Half
| |
(unaudited)
|
2023
|
2022
|
Taxation
|
1,385
|
1,143
|
Tax impact of:
| ||
Non-underlying items within operating profit(a)
|
(111)
|
102
|
Non-underlying items not in operating profit but within net profit(a)
|
(80)
|
(63)
|
Taxation before tax impact of non-underlying items
|
1,194
|
1,182
|
Profit before taxation
|
5,267
|
4,359
|
Share of net (profit)/loss of joint ventures and associates
|
(118)
|
(97)
|
Profit before tax excluding share of net profit/(loss) of joint ventures and associates
|
5,149
|
4,262
|
Non-underlying items within operating profit before tax(a)
|
(308)
|
544
|
Non-underlying items not in operating profit but within net profit before tax
|
103
|
38
|
Profit before tax excluding non-underlying items before tax and share of net profit/ (loss) of joint ventures and associates
|
4,944
|
4,844
|
Effective tax rate (%)
|
26.9
|
26.8
|
Underlying effective tax rate (%)
|
24.2
|
24.4
|
€ million
|
First Half
| |
(unaudited)
|
2023
|
2022
|
Underlying profit attributable to shareholders' equity (see note 6)
|
3,534
|
3,440
|
Impact of translation from current to constant exchange rates and translational hedges
|
330
|
-
|
Impact of price growth in excess of 26% per year in hyperinflationary economies
|
(149)
|
-
|
Constant underlying earnings attributable to shareholders' equity
|
3,715
|
3,440
|
Diluted average number of share units (millions of units)
|
2,536.8
|
2,566.2
|
Constant underlying EPS (€)
|
1.46
|
1.34
|
€ million
|
As at 30 June 2023
|
As at 31 December 2022
|
As at 30 June 2022
|
(unaudited)
| |||
Total financial liabilities
|
(30,708)
|
(29,488)
|
(33,961)
|
Current financial liabilities
|
(6,715)
|
(5,775)
|
(9,032)
|
Non-current financial liabilities
|
(23,993)
|
(23,713)
|
(24,929)
|
Cash and cash equivalents as per balance sheet
|
4,994
|
4,326
|
5,411
|
Cash and cash equivalents as per cash flow statement
|
4,870
|
4,225
|
5,274
|
Add: bank overdrafts deducted therein
|
124
|
101
|
157
|
Less: cash and cash equivalents held for sale
|
-
|
-
|
(20)
|
Other current financial assets
|
1,376
|
1,435
|
1,435
|
Non-current financial asset derivatives that relate to financial liabilities
|
31
|
51
|
60
|
Net debt
|
(24,307)
|
(23,676)
|
(27,055)
|
€ million
|
First Half
| |
(unaudited)
|
2023
|
2022
|
Cash flow from operating activities
|
4,377
|
4,344
|
Income tax paid
|
(1,011)
|
(1,295)
|
Net capital expenditure
|
(548)
|
(593)
|
Net interest paid
|
(364)
|
(217)
|
Free cash flow
|
2,454
|
2,239
|
Net cash flow (used in)/from investing activities
|
(200)
|
(432)
|
Net cash flow (used in)/from financing activities
|
(2,489)
|
(924)
|
Hein Schumacher
|
Graeme Pitkethly
|
Chief Executive Officer
|
Chief Financial Officer
|
24 July 2023
|
Media: Media Relations Team
|
Investors: Investor Relations Team
|
UK +44 78 2527 3767 lucila.zambrano@unilever.com
or +44 77 7999 9683 jonathan.sibun@teneo.com
NL +31 62 375 8385 marlous-den.bieman@unilever.com
or +31 61 500 8293 fleur-van.bruggen@unilever.com
|
investor.relations@unilever.com
|
€ million
|
First Half
| ||
(unaudited)
|
2023
|
2022
|
Change
|
Turnover
|
30,428
|
29,623
|
2.7%
|
Operating profit
|
5,516
|
4,500
|
22.6%
|
Net finance costs
|
(259)
|
(227)
| |
Pensions and similar obligations
|
50
|
22
| |
Finance income
|
208
|
105
| |
Finance costs
|
(517)
|
(354)
| |
Net monetary gain/(loss) arising from hyperinflationary economies
|
(98)
|
(38)
| |
Share of net profit/(loss) of joint ventures and associates
|
118
|
97
| |
Other income/(loss) from non-current investments and associates
|
(10)
|
27
| |
Profit before taxation
|
5,267
|
4,359
|
20.8%
|
Taxation
|
(1,385)
|
(1,143)
| |
Net profit
|
3,882
|
3,216
|
20.7%
|
Attributable to:
| |||
Non-controlling interests
|
334
|
311
| |
Shareholders' equity
|
3,548
|
2,905
|
22.1%
|
Basic earnings per share (euros)
|
1.41
|
1.14 23.7%
|
Diluted earnings per share (euros)
|
1.40
|
1.13 23.6%
|
€ million
|
First Half
| |
(unaudited)
|
2023
|
2022
|
Net profit
|
3,882
|
3,216
|
Other comprehensive income
| ||
Items that will not be reclassified to profit or loss, net of tax:
| ||
Gains/(losses) on equity instruments measured at fair value through other comprehensive income
|
(34)
|
52
|
Remeasurement of defined benefit pension plans
|
(47)
|
1,463
|
Items that may be reclassified subsequently to profit or loss, net of tax:
| ||
Gains/(losses) on cash flow hedges
|
(22)
|
51
|
Currency retranslation gains/(losses)
|
(555)
|
1,309
|
Total comprehensive income
|
3,224
|
6,091
|
Attributable to:
| ||
Non-controlling interests
|
284
|
384
|
Shareholders' equity
|
2,940
|
5,707
|
(unaudited)
| ||||||||
€ million
|
Called
up share
capital
|
Share
premium
account
|
Unification
reserve
|
Other
reserves
|
Retained
profit
|
Total
|
Non-
controlling
interest
|
Total
equity
|
First half - 2023
| ||||||||
01 January 2023
|
92
|
52,844
|
(73,364)
|
(10,804)
|
50,253
|
19,021
|
2,680
|
21,701
|
Profit or loss for the period
|
-
|
-
|
-
|
-
|
3,548
|
3,548
|
334
|
3,882
|
Other comprehensive income, net of tax:
| ||||||||
Gains/(losses) on:
| ||||||||
Equity instruments
|
-
|
-
|
-
|
(33)
|
-
|
(33)
|
(1)
|
(34)
|
Cash flow hedges
|
-
|
-
|
-
|
(22)
|
-
|
(22)
|
-
|
(22)
|
Remeasurements of defined benefit pension plans
|
-
|
-
|
-
|
-
|
(48)
|
(48)
|
1
|
(47)
|
Currency retranslation gains/(losses)(e)
|
-
|
-
|
-
|
(736)
|
231
|
(505)
|
(50)
|
(555)
|
Total comprehensive income
|
-
|
-
|
-
|
(791)
|
3,731
|
2,940
|
284
|
3,224
|
Dividends on ordinary capital
|
-
|
-
|
-
|
-
|
(2,172)
|
(2,172)
|
-
|
(2,172)
|
Repurchase of shares(a)
|
-
|
-
|
-
|
(753)
|
-
|
-753
|
-
|
(753)
|
Movements in treasury shares(b)
|
-
|
-
|
-
|
69
|
(68)
|
1
|
-
|
1
|
Share-based payment credit(c)
|
-
|
-
|
-
|
-
|
159
|
159
|
-
|
159
|
Dividends paid to non-controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
(276)
|
(276)
|
Hedging gain/(loss) transferred to non-financial assets
|
-
|
-
|
-
|
78
|
-
|
78
|
-
|
78
|
Other movements in equity
|
-
|
-
|
-
|
5
|
(22)
|
(17)
|
(24)
|
(41)
|
30 June 2023
|
92
|
52,844
|
(73,364)
|
(12,196)
|
51,881
|
19,257
|
2,664
|
21,921
|
First half - 2022
| ||||||||
1 January 2022
|
92
|
52,844
|
-73,364
|
-9,210
|
46,745
|
17,107
|
2,639
|
19,746
|
Profit or loss for the period
|
-
|
-
|
-
|
-
|
2,905
|
2,905
|
311
|
3,216
|
Other comprehensive income, net of tax:
| ||||||||
Gains/(losses) on:
| ||||||||
Equity instruments
|
-
|
-
|
-
|
44
|
-
|
44
|
8
|
52
|
Cash flow hedges
|
-
|
-
|
-
|
48
|
-
|
48
|
3
|
51
|
Remeasurements of defined benefit pension plans
|
-
|
-
|
-
|
-
|
1,462
|
1,462
|
1
|
1,463
|
Currency retranslation gains/(losses)
|
-
|
-
|
-
|
1,240
|
8
|
1,248
|
61
|
1,309
|
Total comprehensive income
|
-
|
-
|
-
|
1,332
|
4,375
|
5,707
|
384
|
6,091
|
Dividends on ordinary capital
|
-
|
-
|
-
|
-
|
(2,195)
|
(2,195)
|
-
|
(2,195)
|
Repurchase of shares(a)
|
-
|
-
|
-
|
(648)
|
-
|
(648)
|
-
|
(648)
|
Movements in treasury shares(b)
|
-
|
-
|
-
|
99
|
(107)
|
(8)
|
-
|
(8)
|
Share-based payment credit(c)
|
-
|
-
|
-
|
-
|
93
|
93
|
-
|
93
|
Dividends paid to non-controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
(309)
|
(309)
|
Hedging gain/(loss) transferred to non-financial assets
|
-
|
-
|
-
|
(133)
|
-
|
(133)
|
(3)
|
(136)
|
Other movements in equity(d)
|
-
|
-
|
-
|
2
|
216
|
218
|
14
|
232
|
30 June 2022
|
92
|
52,844
|
(73,364)
|
(8,558)
|
49,127
|
20,141
|
2,725
|
22,866
|
(unaudited)
| |||
€ million
|
As at 30 June 2023
|
As at 31 December 2022
|
As at 30 June 2022
|
Non-current assets
| |||
Goodwill
|
21,299
|
21,609
|
21,571
|
Intangible assets
|
18,664
|
18,880
|
18,935
|
Property, plant and equipment
|
10,590
|
10,770
|
10,733
|
Pension asset for funded schemes in surplus
|
4,244
|
4,260
|
6,581
|
Deferred tax assets
|
1,084
|
1,049
|
1,559
|
Financial assets
|
1,220
|
1,154
|
1,286
|
Other non-current assets
|
952
|
942
|
1,023
|
58,053
|
58,664
|
61,688
| |
Current assets
| |||
Inventories
|
5,668
|
5,931
|
5,893
|
Trade and other current receivables
|
8,046
|
7,056
|
7,309
|
Current tax assets
|
254
|
381
|
324
|
Cash and cash equivalents
|
4,994
|
4,326
|
5,411
|
Other financial assets
|
1,376
|
1,435
|
1,435
|
Assets held for sale
|
18
|
28
|
2,832
|
20,356
|
19,157
|
23,204
| |
Total assets
|
78,409
|
77,821
|
84,892
|
Current liabilities
| |||
Financial liabilities
|
6,715
|
5,775
|
9,032
|
Trade payables and other current liabilities
|
17,367
|
18,023
|
17,151
|
Current tax liabilities
|
891
|
877
|
1,327
|
Provisions
|
634
|
748
|
640
|
Liabilities held for sale
|
-
|
4
|
788
|
25,607
|
25,427
|
28,938
| |
Non-current liabilities
| |||
Financial liabilities
|
23,993
|
23,713
|
24,929
|
Non-current tax liabilities
|
280
|
94
|
163
|
Pensions and post-retirement healthcare liabilities:
| |||
Funded schemes in deficit
|
431
|
613
|
362
|
Unfunded schemes
|
1,040
|
1,078
|
1,189
|
Provisions
|
547
|
550
|
621
|
Deferred tax liabilities
|
4,410
|
4,375
|
5,523
|
Other non-current liabilities
|
180
|
270
|
301
|
30,881
|
30,693
|
33,088
| |
Total liabilities
|
56,488
|
56,120
|
62,026
|
Equity
| |||
Shareholders' equity
|
19,257
|
19,021
|
20,141
|
Non-controlling interests
|
2,664
|
2,680
|
2,725
|
Total equity
|
21,921
|
21,701
|
22,866
|
Total liabilities and equity
|
78,409
|
77,821
|
84,892
|
(unaudited)
|
First Half
| |
€ million
|
2023
|
2022
|
Net profit
|
3,882
|
3,216
|
Taxation
|
1,385
|
1,143
|
Share of net (profit)/loss of joint ventures/associates and other (income)/loss from non-current investments and associates
|
(108)
|
(124)
|
Net monetary (gain)/loss arising from hyperinflationary economies
|
98
|
38
|
Net finance costs
|
259
|
227
|
Operating profit
|
5,516
|
4,500
|
Depreciation, amortisation and impairment
|
754
|
842
|
Changes in working capital
|
(1,331)
|
(1,116)
|
Pensions and similar obligations less payments
|
(103)
|
(49)
|
Provisions less payments
|
(122)
|
135
|
Elimination of (profits)/losses on disposals
|
(507)
|
(28)
|
Non-cash charge for share-based compensation
|
159
|
93
|
Other adjustments
|
11
|
(33)
|
Cash flow from operating activities
|
4,377
|
4,344
|
Income tax paid
|
(1,011)
|
(1,295)
|
Net cash flow from operating activities
|
3,366
|
3,049
|
Interest received
|
139
|
106
|
Net capital expenditure
|
(548)
|
(593)
|
Acquisitions and disposals
|
352
|
2
|
Other investing activities
|
(143)
|
53
|
Net cash flow (used in)/from investing activities
|
(200)
|
(432)
|
Dividends paid on ordinary share capital
|
(2,202)
|
(2,176)
|
Interest paid
|
(503)
|
(323)
|
Change in financial liabilities
|
1,230
|
2,500
|
Repurchase of shares
|
(753)
|
(648)
|
Other financing activities
|
(261)
|
(277)
|
Net cash flow (used in)/from financing activities
|
(2,489)
|
(924)
|
Net increase/(decrease) in cash and cash equivalents
|
677
|
1,693
|
Cash and cash equivalents at the beginning of the period
|
4,225
|
3,387
|
Effect of foreign exchange rate changes
|
(32)
|
194
|
Cash and cash equivalents at the end of the period
|
4,870
|
5,274
|
€ million
|
First Half
| |
2023
|
2022
| |
Acquisition and disposal-related credits/(costs) (a)
|
(52)
|
(87)
|
Gain/(loss) on disposal of group companies(b)
|
528
|
21
|
Restructuring costs(c)
|
(184)
|
(359)
|
Impairments(d)
|
(1)
|
(4)
|
Other(e)
|
17
|
(115)
|
Non-underlying items within operating profit before tax
|
308
|
(544)
|
Tax on non-underlying items within operating profit
|
(111)
|
102
|
Non-underlying items within operating profit after tax
|
197
|
(442)
|
Interest related to the UK tax audit of intangible income and centralised services
|
(5)
|
-
|
Net monetary gain/(loss) arising from hyperinflationary economies
|
(98)
|
(38)
|
Non-underlying items not in operating profit but within net profit before tax
|
(103)
|
(38)
|
Tax impact of non-underlying items not in operating profit but within net profit:
| ||
Taxes related to separation of Ekaterra
|
(6)
|
(39)
|
Taxes related to the UK tax audit of intangible income and centralised services
|
1
|
-
|
Hyperinflation adjustment for Argentina and Turkey deferred tax
|
(75)
|
(24)
|
Non-underlying items not in operating profit but within net profit after tax
|
(183)
|
(101)
|
Non-underlying items after tax(f)
|
14
|
(543)
|
Non-controlling interests
|
-
|
(8)
|
Shareholders' equity
|
14
|
(535)
|
Second Quarter
|
Beauty & Wellbeing
|
Personal Care
|
Home Care
|
Nutrition
|
Ice Cream
|
Total
|
Turnover (€ million)
| ||||||
2022
|
2,999
|
3,420
|
3,092
|
3,596
|
2,703
|
15,810
|
2023
|
3,143
|
3,519
|
3,057
|
3,260
|
2,760
|
15,739
|
Change (%)
|
4.8
|
2.9
|
(1.1)
|
(9.3)
|
2.1
|
(0.4)
|
Impact of:
| ||||||
Acquisitions (%)
|
3.7
|
-
|
-
|
-
|
-
|
0.7
|
Disposals (%)
|
(1.7)
|
(0.6)
|
-
|
(12.6)
|
-
|
(3.3)
|
Currency-related items (%), of which:
|
(5.5)
|
(5)
|
(7.3)
|
(4.7)
|
(3.3)
|
(5.2)
|
Exchange rates changes (%)
|
(6.7)
|
(6.6)
|
(9.9)
|
(6.1)
|
(5.8)
|
(7)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.4
|
1.7
|
2.8
|
1.4
|
2.7
|
2
|
Underlying sales growth (%)
|
8.8
|
9.0
|
6.7
|
8.9
|
5.6
|
7.9
|
Price* (%)
|
3.7
|
5.4
|
9.0
|
11.8
|
12.1
|
8.2
|
Volume (%)
|
4.9
|
3.4
|
(2.1)
|
(2.6)
|
(5.8)
|
(0.3)
|
First Half
|
Beauty & Wellbeing
|
Personal Care
|
Home Care
|
Nutrition
|
Ice Cream
|
Total
|
Turnover (€ million)
| ||||||
2022
|
5,731
|
6,445
|
6,024
|
7,107
|
4,316
|
29,623
|
2023
|
6,225
|
6,911
|
6,205
|
6,601
|
4,486
|
30,428
|
Change (%)
|
8.6
|
7.3
|
3
|
(7.1)
|
3.9
|
2.7
|
Impact of:
| ||||||
Acquisitions (%)
|
3.6
|
-
|
-
|
-
|
-
|
0.7
|
Disposals (%)
|
(1)
|
(0.3)
|
-
|
(13.1)
|
-
|
(3.4)
|
Currency-related items (%), of which:
|
(3)
|
(2.9)
|
(5)
|
(3.2)
|
(1.7)
|
(3.2)
|
Exchange rates changes (%)
|
(4.3)
|
(4.5)
|
(7.7)
|
(4.5)
|
(4)
|
(5)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.3
|
1.7
|
2.9
|
1.3
|
2.4
|
1.9
|
Underlying sales growth (%)
|
9.1
|
10.8
|
8.4
|
10.4
|
5.7
|
9.1
|
Price* (%)
|
5.1
|
7.3
|
11.2
|
12.6
|
11.5
|
9.4
|
Volume (%)
|
3.8
|
3.2
|
(2.5)
|
(1.9)
|
(5.2)
|
(0.2)
|
Operating profit (€ million)
| ||||||
2022
|
995
|
1,174
|
609
|
1,124
|
598
|
4,500
|
2023
|
1,237
|
1,691
|
731
|
1,213
|
644
|
5,516
|
Underlying operating profit (€ million)
| ||||||
2022
|
1,083
|
1,295
|
723
|
1,253
|
690
|
5,044
|
2023
|
1,179
|
1,381
|
763
|
1,214
|
671
|
5,208
|
Operating margin (%)
| ||||||
2022
|
17.4
|
18.2
|
10.1
|
15.8
|
13.9
|
15.2
|
2023
|
19.9
|
24.5
|
11.8
|
18.4
|
14.4
|
18.1
|
Underlying operating margin (%)
| ||||||
2022
|
18.9
|
20.1
|
12.0
|
17.6
|
16.0
|
17.0
|
2023
|
18.9
|
20.0
|
12.3
|
18.4
|
15.0
|
17.1
|
Second Quarter
|
Asia Pacific Africa
|
The Americas
|
Europe
|
Total
|
Turnover (€ million)
| ||||
2022
|
7,061
|
5,414
|
3,335
|
15,810
|
2023
|
6,699
|
5,700
|
3,340
|
15,739
|
Change (%)
|
(5.1)
|
5.3
|
0.1
|
(0.4)
|
Impact of:
| ||||
Acquisitions (%)
|
-
|
2.0
|
-
|
0.7
|
Disposals (%)
|
(3.3)
|
(3.4)
|
(3.1)
|
(3.3)
|
Currency-related items (%), of which:
|
(9.4)
|
(2.4)
|
(0.9)
|
(5.2)
|
Exchange rate changes (%)
|
(11.2)
|
(5.4)
|
(0.9)
|
(7.0)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.9
|
3.2
|
-
|
2.0
|
Underlying sales growth (%)
|
8.3
|
9.5
|
4.3
|
7.9
|
Price* (%)
|
6.5
|
6.4
|
15.5
|
8.2
|
Volume (%)
|
1.8
|
2.9
|
(9.7)
|
(0.3)
|
First Half
|
Asia Pacific Africa
|
The Americas
|
Europe
|
Total
|
Turnover (€ million)
| ||||
2022
|
13,701
|
9,941
|
5,982
|
29,623
|
2023
|
13,421
|
10,956
|
6,051
|
30,428
|
Change (%)
|
(2.0)
|
10.2
|
1.2
|
2.7
|
Impact of:
| ||||
Acquisitions (%)
|
-
|
2.0
|
-
|
0.7
|
Disposals (%)
|
(3.6)
|
(2.9)
|
(3.7)
|
(3.4)
|
Currency-related items (%), of which
|
(6.9)
|
0.5
|
(1.3)
|
(3.2)
|
Exchange rate changes (%)
|
(8.6)
|
(2.3)
|
(1.3)
|
(5.0)
|
Extreme price growth in hyperinflationary markets* (%)
|
1.9
|
2.9
|
-
|
1.9
|
Underlying sales growth (%)
|
9.1
|
10.6
|
6.4
|
9.1
|
Price* (%)
|
8.0
|
8.6
|
14.2
|
9.4
|
Volume (%)
|
1.1
|
1.8
|
(6.8)
|
(0.2)
|
First half
| ||||||
2023
|
2022
| |||||
€ million
|
Before tax
|
Tax (charge)/credit
|
After tax
|
Before tax
|
Tax (charge)/credit
|
After tax
|
Gains/(losses) on:
| ||||||
Equity instruments at fair value through other comprehensive income
|
(34)
|
-
|
(34)
|
49
|
3
|
52
|
Cash flow hedges
|
(20)
|
(2)
|
(22)
|
26
|
25
|
51
|
Remeasurements of defined benefit pension plans
|
(90)
|
43
|
(47)
|
2,037
|
(574)
|
1,463
|
Currency retranslation gains/(losses)
|
(535)
|
(20)
|
(555)
|
1,317
|
(8)
|
1,309
|
Other comprehensive income
|
(679)
|
21
|
(658)
|
3,429
|
(554)
|
2,875
|
First Half
| ||
2023
|
2022
| |
EPS - Basic
| ||
Net profit attributable to shareholders' equity (€ million)
|
3,548
|
2,905
|
Average number of shares (millions of share units)
|
2,523.9
|
2,557.3
|
EPS - basic (€)
|
1.41
|
1.14
|
EPS - Diluted
| ||
Net profit attributable to shareholders' equity (€ million)
|
3,548
|
2,905
|
Adjusted average number of shares (millions of share units)
|
2,536.8
|
2,566.2
|
EPS - diluted (€)
|
1.40
|
1.13
|
Net profit attributable to shareholders' equity (€ million)
|
3,548
|
2,905
|
Post-tax impact of non-underlying items attributable to shareholders' equity (see note 2)
|
(14)
|
535
|
Underlying profit attributable to shareholders' equity
|
3,534
|
3,440
|
Adjusted average number of shares (millions of share units)
|
2,536.8
|
2,566.2
|
Underlying EPS - diluted (€)
|
1.39
|
1.34
|
Millions
| |
Number of shares at 31 December 2022 (net of treasury shares)
|
2,529.0
|
Net movements in shares under incentive schemes
|
1.5
|
Shares repurchased under the share buyback programme
|
(15.5)
|
Number of shares at 30 June 2023
|
2,515.0
|
Deal completion date
|
Acquired/disposed business
|
10 January 2023
|
Acquired 51% of Zywie Ventures Private Limited ("OZiva"), a leading plant-based, and clean-label consumer wellness brand focused on the need spaces such as Lifestyle Protein, Hair & Beauty Supplements and Women's health.
|
1 May 2023
|
Sold Suave brand in North America to Yellow Wood Partners LLC. The Suave beauty and personal care brand includes hair care, skin care, skin cleansing and deodorant products.
|
30 June 2023
|
31 December 2022
|
30 June 2022
| |||||||
Current
|
Non-current
|
Total
|
Current
|
Non-current
|
Total
|
Current
|
Non-current
|
Total
| |
Cash and cash equivalents
| |||||||||
Cash at bank and in hand
|
2,790
|
-
|
2,790
|
2,553
|
-
|
2,553
|
2,730
|
-
|
2,730
|
Short-term deposits(a)
|
1,804
|
-
|
1,804
|
1,743
|
-
|
1,743
|
2,481
|
-
|
2,481
|
Other cash equivalents(b)
|
400
|
-
|
400
|
30
|
-
|
30
|
200
|
-
|
200
|
4,994
|
-
|
4,994
|
4,326
|
-
|
4,326
|
5,411
|
-
|
5,411
| |
Other financial assets
| |||||||||
Financial assets at amortised cost(c)
|
727
|
352
|
1,079
|
772
|
232
|
1,004
|
756
|
220
|
976
|
Financial assets at fair value through other comprehensive income(d)
|
-
|
438
|
438
|
-
|
407
|
407
|
-
|
547
|
547
|
Financial assets at fair value through profit or loss:
| |||||||||
Derivatives
|
36
|
31
|
67
|
238
|
51
|
289
|
264
|
60
|
324
|
Other(e)
|
613
|
399
|
1,012
|
425
|
464
|
889
|
415
|
459
|
874
|
1,376
|
1,220
|
2,596
|
1,435
|
1,154
|
2,589
|
1,435
|
1,286
|
2,721
| |
Total financial assets(f)
|
6,370
|
1,220
|
7,590
|
5,761
|
1,154
|
6,915
|
6,846
|
1,286
|
8,132
|
€ million
|
Fair value
|
Carrying amount
| ||||
As at 30 June 2023
|
As at 31 December 2022
|
As at 30 June 2022
|
As at 30 June 2023
|
As at 31 December 2022
|
As at 30 June 2022
| |
Financial assets
| ||||||
Cash and cash equivalents
|
4,994
|
4,326
|
5,411
|
4,994
|
4,326
|
5,411
|
Financial assets at amortised cost
|
1,079
|
1,004
|
976
|
1,079
|
1,004
|
976
|
Financial assets at fair value through other comprehensive income
|
438
|
407
|
547
|
438
|
407
|
547
|
Financial assets at fair value through profit and loss:
| ||||||
Derivatives
|
67
|
289
|
324
|
67
|
289
|
324
|
Other
|
1,012
|
889
|
874
|
1,012
|
889
|
874
|
7,590
|
6,915
|
8,132
|
7,590
|
6,915
|
8,132
| |
Financial liabilities
| ||||||
Bank loans and overdrafts
|
(606)
|
(519)
|
(540)
|
(606)
|
(519)
|
(540)
|
Bonds and other loans
|
(26,265)
|
(25,136)
|
(30,089)
|
(27,599)
|
(26,512)
|
(31,007)
|
Lease liabilities
|
(1,428)
|
(1,408)
|
(1,585)
|
(1,428)
|
(1,408)
|
(1,585)
|
Derivatives
|
(618)
|
(631)
|
(548)
|
(618)
|
(631)
|
(548)
|
Other financial liabilities
|
(457)
|
(418)
|
(281)
|
(457)
|
(418)
|
(281)
|
(29,374)
|
(28,112)
|
(33,043)
|
(30,708)
|
(29,488)
|
(33,961)
|
€ million
|
As at 30 June 2023
|
As at 31 December 2022
|
As at 30 June 2022
| ||||||
Level 1
|
Level 2
|
Level 3
|
Level 1
|
Level 2
|
Level 3
|
Level 1
|
Level 2
|
Level 3
| |
Assets at fair value
| |||||||||
Financial assets at fair value through other comprehensive income
|
14
|
3
|
421
|
5
|
3
|
399
|
11
|
3
|
533
|
Financial assets at fair value through profit or loss:
| |||||||||
Derivatives(a)
|
-
|
142
|
-
|
-
|
378
|
-
|
-
|
505
|
-
|
Other
|
613
|
-
|
399
|
428
|
-
|
461
|
420
|
-
|
454
|
Liabilities at fair value
| |||||||||
Derivatives(b)
|
-
|
(718)
|
-
|
-
|
(784)
|
-
|
-
|
(729)
|
-
|
Contingent consideration
|
-
|
-
|
(123)
|
-
|
-
|
(164)
|
-
|
-
|
(175)
|
Per Unilever PLC ordinary share (traded on the London Stock Exchange):
|
£0.3700
|
Per Unilever PLC ordinary share (traded on Euronext in Amsterdam):
|
€0.4268
|
Per Unilever PLC American Depositary Receipt:
|
US$0.4746
|
Announcement date
|
Ex-Dividend Date
|
Record Date
|
Payment Date
| |
Q2 2023 Dividend
|
25 July 2023
|
03 August 2023
|
04 August 2023
|
31 August 2023
|
Q3 2023 Dividend
|
26 October 2023
|
16 November 2023
|
17 November 2023
|
08 December 2023
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Unilever plc published this content on 25 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 July 2023 10:31:29 UTC.